Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial
Research output: Contribution to journal › Journal article › Research › peer-review
Positron emission tomography (PET)/CT has become a widely used technology for preoperative staging of non-small cell lung cancer (NSCLC). Two recent randomized controlled trials (RCT) have established its efficacy over conventional staging, but no studies have assessed its cost-effectiveness. The objective of this study was to assess the cost-effectiveness of PET/CT as an adjunct to conventional workup for preoperative staging of NSCLC.
| Original language | English |
|---|---|
| Journal | European Journal of Nuclear Medicine and Molecular Imaging |
| Volume | 38 |
| Issue number | 5 |
| Pages (from-to) | 802-9 |
| Number of pages | 8 |
| ISSN | 1619-7070 |
| DOIs | |
| Publication status | Published - 2011 |
ID: 40161630